|
1
|
Liu Y: Cellular and molecular mechanisms
of renal fibrosis. Nat Rev Nephrol. 7:684–696. 2011. View Article : Google Scholar :
|
|
2
|
Zeisberg M and Neilson EG: Mechanisms of
tubulointerstitial fibrosis. J Am Soc Nephrol. 21:1819–1834. 2010.
View Article : Google Scholar
|
|
3
|
Boor P, Sebekova K, Ostendorf T and Floege
J: Treatment targets in renal fibrosis. Nephrol Dial Transplant.
22:3391–3407. 2007. View Article : Google Scholar
|
|
4
|
Ramos AM, Gonzalez-Guerrero C, Sanz A,
Sanchez-Niño MD, Rodríguez-Osorio L, Martín-Cleary C,
Fernández-Fernández B, Ruiz-Ortega M and Ortiz A: Designing drugs
that combat kidney damage. Expert Opin Drug Discov. 10:541–556.
2015. View Article : Google Scholar
|
|
5
|
Ashburn TT and Thor KB: Drug
repositioning: Identifying and developing new uses for existing
drugs. Nat Rev Drug Discov. 3:673–683. 2004. View Article : Google Scholar
|
|
6
|
Nuki G: Colchicine: Its mechanism of
action and efficacy in crystal-induced inflammation. Curr Rheumatol
Rep. 10:218–227. 2008. View Article : Google Scholar
|
|
7
|
Hastie SB: Interactions of colchicine with
tubulin. Pharmacol Ther. 51:377–401. 1991. View Article : Google Scholar
|
|
8
|
Slobodnick A, Shah B, Pillinger MH and
Krasnokutsky S: Colchicine: Old and new. Am J Med. 128:461–470.
2015. View Article : Google Scholar
|
|
9
|
Rodríguez L, Cerbón-Ambriz J and Muñoz ML:
Effects of colchicine and colchiceine in a biochemical model of
liver injury and fibrosis. Arch Med Res. 29:109–116. 1998.
|
|
10
|
Ledwozyw A: The effect of colchicine and
vinblastine on bleomycin-induced lung fibrosis in rats. Acta
Physiol Hung. 82:383–389. 1994.
|
|
11
|
Disel U, Paydas S, Dogan A, Gulfiliz G and
Yavuz S: Effect of colchicine on cyclosporine nephrotoxicity,
reduction of TGF-beta overexpression, apoptosis, and oxidative
damage: An experimental animal study. Transplant Proc.
36:1372–1376. 2004. View Article : Google Scholar
|
|
12
|
McClurkin C Jr, Phan SH, Hsu CH, Patel SR,
Spicker JK, Kshirsagar AM, Yuan WY and Wiggins RC: Moderate
protection of renal function and reduction of fibrosis by
colchicine in a model of anti-GBM disease in the rabbit. J Am Soc
Nephrol. 1:257–265. 1990.
|
|
13
|
Li JJ, Lee SH, Kim DK, Jin R, Jung DS,
Kwak SJ, Kim SH, Han SH, Lee JE, Moon SJ, et al: Colchicine
attenuates inflammatory cell infiltration and extracellular matrix
accumulation in diabetic nephropathy. Am J Physiol Renal Physiol.
297:F200–F209. 2009. View Article : Google Scholar
|
|
14
|
Guan T, Gao B, Chen G, Chen X, Janssen M,
Uttarwar L, Ingram AJ and Krepinsky JC: Colchicine attenuates renal
injury in a model of hypertensive chronic kidney disease. Am J
Physiol Renal Physiol. 305:F1466–F1476. 2013. View Article : Google Scholar
|
|
15
|
Klahr S and Pukerson ML: The
pathophysiology of obstructive nephropathy: The role of vasoactive
compounds in the hemodynamic and structural abnormalities of the
obstructed kidney. Am J Kidney Dis. 23:219–223. 1994. View Article : Google Scholar
|
|
16
|
Diamond JR, Kees-Folts D, Ding G, Frye JE
and Restrepo NC: Macrophages, monocyte chemoattractant peptide-1
and TGF-beta 1 in experimental hydronephrosis. Am J Physiol.
266:F926–F933. 1994.
|
|
17
|
Kaneto H, Morrissey J and Klahr S:
Increased expression of TGF-beta 1 mRNA in the obstructed kidney of
rats with unilateral ureteral ligation. Kidney Int. 44:313–321.
1993. View Article : Google Scholar
|
|
18
|
Satoh M, Kashihara N, Yamasaki Y, Maruyama
K, Okamoto K, Maeshima Y, Sugiyama H, Sugaya T, Murakami K and
Makino H: Renal interstitial fibrosis is reduced in angiotensin II
type 1a receptor-deficient mice. J Am Soc Nephrol. 12:317–325.
2001.
|
|
19
|
Du F, Li S, Wang T, Zhang HY, Li DT, Du ZX
and Wang HQ: Implication of Bcl-2-associated athanogene 3 in
fibroblast growth factor-2-mediated epithelial-mesenchymal
transition in renal epithelial cells. Exp Biol Med (Maywood).
240:566–575. 2015. View Article : Google Scholar :
|
|
20
|
Satoh M, Fujimoto S, Horike H, Ozeki M,
Nagasu H, Tomita N, Sasaki T and Kashihara N: Mitochondrial
damage-induced impairment of angiogenesis in the aging rat kidney.
Lab Invest. 91:190–202. 2011. View Article : Google Scholar
|
|
21
|
Clark K, Karsch-Mizrachi I, Lipman DJ,
Ostell J and Sayers EW: GenBank. Nucleic Acids Res. 44:D67–D72.
2016. View Article : Google Scholar
|
|
22
|
Dhanasekaran S, Doherty TM and Kenneth J;
TB Trials Study Group, : Comparison of different standards for
real-time PCR-based absolute quantification. J Immunol Methods.
354:34–39. 2010. View Article : Google Scholar
|
|
23
|
Bolick DT, Whetzel AM, Skaflen M, Deem TL,
Lee J and Hedrick CC: Absence of the G protein-coupled receptor G2A
in mice promotes monocyte/endothelial interactions in aorta. Circ
Res. 100:572–580. 2007. View Article : Google Scholar
|
|
24
|
Yurdakul S, Mat C, Tüzün Y, Ozyazgan Y,
Hamuryudan V, Uysal O, Senocak M and Yazici H: A double-blind trial
of colchicine in Behçet's syndrome. Arthritis Rheum. 44:2686–2692.
2001. View Article : Google Scholar
|
|
25
|
Kaplan MM and Gershwin ME: Primary biliary
cirrhosis. N Engl J Med. 353:1261–1273. 2005. View Article : Google Scholar
|
|
26
|
La Regina M, Ben-Chetrit E, Gasparyan AY,
Livneh A, Ozdogan H and Manna R: Current trends in colchicine
treatment in familial Mediterranean fever. Clin Exp Rheumatol. 31(3
Suppl 77): S41–S46. 2013.
|
|
27
|
Deftereos S, Giannopoulos G, Papoutsidakis
N, Panagopoulou V, Kossyvakis C, Raisakis K, Cleman MW and
Stefanadis C: Colchicine and the heart: Pushing the envelope. J Am
Coll Cardiol. 62:1817–1825. 2013. View Article : Google Scholar
|
|
28
|
Murali A and Rajalingam K: Small Rho
GTPases in the control of cell shape and mobility. Cell Mol Life
Sci. 71:1703–1721. 2014. View Article : Google Scholar
|
|
29
|
Pellegrin S and Mellor H: Actin stress
fibres. J Cell Sci. 120:3491–3499. 2007. View Article : Google Scholar
|
|
30
|
Allen WE, Zicha D, Ridley AJ and Jones GE:
A role for Cdc42 in macrophage chemotaxis. J Cell Biol.
141:1147–1157. 1998. View Article : Google Scholar :
|
|
31
|
Takeda Y, Nishikimi T, Akimoto K, Matsuoka
H and Ishimitsu T: Beneficial effects of a combination of
Rho-kinase inhibitor and ACE inhibitor on tubulointerstitial
fibrosis induced by unilateral ureteral obstruction. Hypertens Res.
33:965–973. 2010. View Article : Google Scholar
|
|
32
|
Picard N, Baum O, Vogetseder A, Kaissling
B and Le Hir M: Origin of renal myofibroblasts in the model of
unilateral ureter obstruction in the rat. Histochem Cell Biol.
130:141–155. 2008. View Article : Google Scholar :
|
|
33
|
Mack M and Yanagita M: Origin of
myofibroblasts and cellular events triggering fibrosis. Kidney Int.
87:297–307. 2015. View Article : Google Scholar
|
|
34
|
Zeisberg M and Kalluri R: The role of
epithelial-to-mesenchymal transition in renal fibrosis. J Mol Med
(Berl). 82:175–181. 2004. View Article : Google Scholar
|
